Apollo Medical Holdings, Inc. (AMEH) Tops Q2 EPS by 4c; Offers FY22 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AMEH Hot Sheet
Join SI Premium – FREE
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) reported Q2 EPS of $0.25, $0.04 better than the analyst estimate of $0.21. Revenue for the quarter came in at $269.7 million versus the consensus estimate of $243.76 million.
GUIDANCE:
Apollo Medical Holdings, Inc. sees FY2022 revenue of $1.055-1.085 billion, versus the consensus of $1.06 billion.
For earnings history and earnings-related data on Apollo Medical Holdings, Inc. (AMEH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- BillionToOne, Inc. (BLLN) Tops Q3 EPS by 23c; Offers Guidance
- ArcelorMittal (MT) Tops Q3 EPS by 36c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
